Oxford Events, the new replacement for OxTalks, will launch on 16th March. From now until the launch of Oxford Events, new events cannot be published or edited on OxTalks while all existing records are migrated to the new platform. The existing OxTalks site will remain available to view during this period.
From 16th, Oxford Events will launch on a new website: events.ox.ac.uk, and event submissions will resume. You will need a Halo login to submit events. Full details are available on the Staff Gateway.
Namir is VP of the Infectious Diseases organisation and a member of the management team at Immunocore Ltd. In his time at the company, Namir has been responsible for building the biology and translational organisation to deliver novel immunotherapies, based on the company’s platform technology, into early phase trials. Namir has also been overseeing the first in human trial with the first in class IMCgp100 immunotherapy for the treatment of malignant melanoma and, is now overseeing the company’s Infectious Diseases Unit. Prior to joining Immunocore in April 2009, Namir was a Group Leader at GSK within Discovery Research, delivering novel assays for the screening of compounds targeting a variety of disease indications. Namir received his DPhil from the Cellular Immunology Unit at the University of Oxford, and has given talks, authored papers and book chapters on the application of immunotherapies to cancers and infectious diseases.
